Howard M. Guttman
Advertisement
Howard M. Guttman is a pricipal of Guttman Development Strategies.
Articles by Howard M. Guttman
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
How Are Regulatory Factors Impacting Biosimilars
2
Obsidian Therapeutics and Galera Therapeutics Enter $350 Million Merger Agreement
3
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
4
Pharma Finance Roundup: Platform Innovation Drives Biotech Investment Across Oncology and Immunology
5